JCRB0627 KYM-1
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | JCRB0627 | Cell Name | KYM-1 |
|---|---|---|---|
| Profile | Human rhabdomyosarcoma cell line derived from neck tumor. | Other Name | KYM-1 |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | 9-month-old |
| Identity | available | Tissue for Primary Cancer | sarcoma |
| Case history | Metastasis | ||
| Tissue Metastasized | Genetics | neck tumor, rhabdomyosarcoma | |
| Life Span | infinite | Crisis PDL | |
| Morphology | lymphocyte-like | Character | neck tumor, rhabdomyosarcoma |
| Classify | tumor | Established by | Sekiguchi,M. |
| Registered by | Sekiguchi,M. | Regulation for Distribution | |
| Comment | Plasminogen activator, hyaluronic acid and alkaline phosphatase were highly produced. The KYM-1 is unique by STR-PCR among 219 cell lines on 04/22/2001. | Year | 1986 |
| Medium | DM160 medium with 10% fetal calf serum. | Methods for Passages | dilution (because of suspension culture) |
| Cell Number on Passage | not defined | Race | Japanese |
| CO2 Conc. | 5 % | Tissue Sampling | neck |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:1960402 | A cytotoxicity assay for tumour necrosis factor using a human rhabdomyosarcoma cell line. Meager A J Immunol Methods. 1991 Nov 5;144(1):141-3 |
| Pubmed id:3830265 | Characterization of a human rhabdomyosarcoma cell strain in tissue culture. Sekiguchi M,Shiroko Y,Suzuki T,Imada M,Miyahara M,Fujii G Biomed Pharmacother. 1985;39(7):372-80 |
| Pubmed id:360802 | Postoperative astigmatism and the operating microscope. Robertson IF Adv Ophthalmol. 1978;37():117-21 |
| Images |
|---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | JCRB0627 | Cell Name | |
|---|---|---|---|
| LOT No. | 02142012 | Lot Specification | distribution |
| Medium | A 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F12 medium supplemented with 10% fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
| Cell Density at Seeding | 1.4 - 2.5 x 10^5 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA |
| Doubling Time | approx. 26 hrs | Cell Number in Vial (cells/1ml) | 1.7 x 10^6 |
| Viability at cell freezing (%) | 63.7 | Antibiotics Used | free |
| Passage Number | Unknown (6 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Yes | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - culture medium | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0627 | Cell Name | |
|---|---|---|---|
| LOT No. | 030499 | Lot Specification | distribution |
| Medium | DM-160 medium with 10% fetal calf serum DM-160 may be substituted by DMEM:F12=1:1 | Temperature | 37 C |
| Cell Density at Seeding | 1-2 x 10^5 cells/ml | Methods for Passages | Weakly adhesive. Suspend the cells with pipetting and dilute to medium. |
| Doubling Time | D.T.=ca 41 hrs | Cell Number in Vial (cells/1ml) | 4.0 x 10^6 |
| Viability at cell freezing (%) | 80.0 | Antibiotics Used | free |
| Passage Number | P6* | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD, MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0627 | Cell Name | |
|---|---|---|---|
| LOT No. | 950206 | Lot Specification | distribution |
| Medium | DM160 + FCS 10% | Temperature | 37 |
| Cell Density at Seeding | Methods for Passages | dilution | |
| Doubling Time | Cell Number in Vial (cells/1ml) | ||
| Viability at cell freezing (%) | Antibiotics Used | kanamycin 50 ug/ml | |
| Passage Number | PDL | ||
| Sterility: MYCOPLASMA | Sterility: BACTERIA | ||
| Sterility: FUNGI | Isozyme Analysis | ||
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Exoteric Gene | ||
| Medium for Freezing | CO2 Conc. | ||
| Viability immediately after thawing (%) | Additional information |
| Cell No. | JCRB0627 | Cell Name | KYM-1 |
|---|---|---|---|
| LOT No. | 12152021 | Lot Specification | distribution |
| Medium | 1:1 mixture of Dulbecco's modified Eagle's medium and Ham's F-12 medium with 10% fetal bovine serum (FBS; Biowest Cat. # S1820-500) | Temperature | 37 C |
| Cell Density at Seeding | 0.6 - 1.9 x 10^5 cells/mL | Methods for Passages | Weakly adhesive. Cells were harvested by pipetting or by treatment with 0.25% trypsin and 0.02% EDTA. |
| Doubling Time | approx. 18 hrs. | Cell Number in Vial (cells/1ml) | 2.4 x 10^6 |
| Viability at cell freezing (%) | 98 | Antibiotics Used | free |
| Passage Number | Unknown (7 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Y/N | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - DMEM/F-12 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 89 | Additional information |
| Cell No. | JCRB0627 | Cell Name | KYM-1 |
|---|---|---|---|
| LOT No. | 11022023 | Lot Specification | distribution |
| Medium | DMEM/ F12(1/1) medium (SIGMA, #D8062) with 10% heat inactivated fetal bovine serum (SIGMA, Cat#172012, Lot#12J396) | Temperature | 37 C |
| Cell Density at Seeding | 7.12-7.60x10^6 cells/ml | Methods for Passages | dilution |
| Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.76x10^6 |
| Viability at cell freezing (%) | 90 | Antibiotics Used | free |
| Passage Number | p6* | PDL | NT |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | |
| Chromosome Mode | NT | Chromosome Information | NT |
| Surface Antigen | NT | DNA Profile (STR) | D5S818:11,14 D13S317:8 D7S820:11 D16S539:9,10 VWA:17 TH01:7,9 AM:X TPOX:8,11 CSF1PO:12 |
| Adhesion | No | Exoteric Gene | NT |
| Medium for Freezing | BAMBANKER (LYMPHOTEC Inc., CS-02-001, NIPPON Genetics Co., LTD) | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | 75 | Additional information |
| Images |
|---|
|
|







